Abstract
Background Although it can result in serious complications due to its narrow therapeutic index, warfarin is widely used in the treatment and prevention of thromboembolic disorders. However, patients’ adherence and knowledge are determinants of therapeutic success. Objective We sought to validate instruments to provide a reliable means of identifying gaps in patient understanding and nonadherence to inform targeted pharmacists’ interventions to improve these measures. Methods A cross-sectional survey was conducted. Patients’ knowledge about warfarin was rated using an Arabic-language tool. Medication adherence was assessed using the eight-item Morisky Medication Adherence Scale (MMAS-8). The international normalized ratio (INR) control was quantified by the Rosendaal Method. Setting At the Security Forces hospital anticoagulant clinic (ACC), Riyadh. Main outcome measure Validity of a Knowledge and adherence tool. Results Totally, 101 patients completed the questionnaires. Interestingly, the knowledge tool demonstrated good internal consistency (total Cronbach’s alpha = 0.75) and significant concurrent validity with adherence levels. Fifty-two patients were classified as having unsatisfactory knowledge. Deficiency in knowledge was most obvious with respect to the consequences of missing a dose and when to seek immediate medical attention. The MMAS-8 had moderate reliability (Cronbach’s alpha = 0.65); however, its concurrent validity with good INR control was not demonstrated. Conclusions This study revealed high prevalence of nonadherence and poor knowledge in the population visiting the ACC. Given that available knowledge and adherence tools seemed to have little validity in predicting clinical outcomes, structured tools should be designed, considering progression in clinical outcomes with future pharmacists’ interventions.
Similar content being viewed by others
References
Larsen T, Skjøth F, Nielsen P, Kjældgaard J, Lip G. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ. 2016;353:i3189.
Alquwaizani M, Buckley L, Adams C, Fanikos J. Anticoagulants: a review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep. 2013;1(2):83–97.
Gurwitz J, Field T, Radford M, Harrold L, Becker R, Reed G, et al. The safety of warfarin therapy in the nursing home setting. Am J Med. 2007;120(6):539–44.
Abe J, Umetsu R, Kato Y, Ueda N, Nakayama Y, Suzuki Y, et al. Evaluation of dabigatran- and warfarin-associated hemorrhagic events using the FDA-adverse event reporting system database stratified by age. Int Med Sci. 2015;12(4):312–21.
Seet R, Rabinstein A, Christianson T, Petty G, Brown R. Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. J Stroke Cerebrovasc Dis. 2013;22(4):561–9.
Alyousif S, Alsaileek A. Quality of anticoagulation control among patients with atrial fibrillation: an experience of a tertiary care center in Saudi Arabia. J Saudi Heart Assoc. 2016;28(4):239–43.
Carrasco-Garrido P, de Andrés L, Barrera V, de Miguel G, Jiménez-García R. Trends of adverse drug reactions related-hospitalizations in Spain (2001–2006). BMC Health Serv Res. 2010;10(1):287.
Sudlow C, Rodgers H, Kenny R, Thomson R. How to do it: service provision and use of anticoagulants in atrial fibrillation. BMJ. 1995;311:558–60.
Taylor F, Ramsay M, Renton A, Cohen H. Methods for managing the increased workload in anticoagulant clinics [letter]. BMJ. 1996;312:286.
Testa S, Zimmermann A, Cancellieri E, Bassi L, Paoletti O. Telemedicine for managing patients on oral anticoagulant therapy. In: Graschew G, Rakowsky S, editors. Telemedicine techniques and applications. 2014. ISBN: 978-953-307-354-5. www.intechopen.com.
Dib J, Mohammed K, Momattin H, Alshehri A. Implementation of pharmacist-managed anticoagulation clinic in a Saudi Arabian health center. Hosp Pharm. 2014;49(3):260–8.
Mayet A. Association between oral anticoagulation knowledge, anticoagulation control, and demographic characteristics of patients attending an anticoagulation clinic in Saudi Arabia: a cross-sectional prospective evaluation. Trop J Pharm Res. 2015;14(7):1285–91.
Mayet A. Patient adherence to warfarin therapy and its impact on anticoagulation control. Saudi Pharm J. 2016;24(1):29–34.
Bayoumy NM, Al-Omair SF, Musallam NA, Al-Deghaither NY, Al-Sadoun NA. Compliance with and awareness about long-term oral anticoagulant therapy among Saudi patients in a university hospital, Riyadh, Saudi Arabia. J Appl Hematol. 2016;7(1):10–6.
Elbur A, Albarraq A, Maugrabi M, Alharthi S. Knowledge of, satisfaction with and adherence to oral anticoagulant drugs among patients in King Fasial Hospital. Int J Pharm Sci Rev Res. 2015;31(1):274–80.
Matchar D, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs C, et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608–20.
Wofford J, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res. 2008;8:40.
Katusiime B, Corlett S, Reeve J, Krska J. Measuring medicine-related experiences from the patient perspective: a systematic review. Patient Relat Outcome Meas. 2016;7:157–71.
Nasser S, Mullan J, Bajorek B. Challenges of older patients’ knowledge about warfarin therapy. J Prim Care Commun Health. 2012;3(1):65–74.
Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med. 2006;119(2):166.e7–16.
Zeolla M. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633–8.
Briggs A, Jackson T, Bruce S, Shapiro N. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40–59.
Khudair I, Hanssens Y. Evaluation of patients’ knowledge on warfarin in outpatient anticoagluant clinics in a teaching hosiptal in Qatar. Saudi Med J. 2010;31(6):672–7.
Morisky D, Green L, Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
Wang Y, Kong M, Ko Y. Comparison of three medication adherence measures in patients taking warfarin. J Thromb Thrombolysis. 2013;36(4):416–21.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Glanz K, Scholl TO. Intervention strategies to improve adherence among hypertensives: review and recommendations. Patient Couns Health Educ. 1982;4(1):14–28.
Sweileh W, Aker O, Hamooz S. Rate of compliance among patients with diabetes mellitus and hypertension. An-Najah Univ J Res. (N. Sc.). 2005;19(1):1–11.
Jamous R, Sweileh W, Abu-Taha A, Sawalha A, Zyoud S, Morisky D. Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm. 2011;33(6):942–8.
Morisky D, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.
Wang Y, Kong M, Ko Y. Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thromb Haemost. 2012;108(4):789–95.
Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–4.
Hirsh J, Dalen J, Anderson D, Poller L, Bussey H, Ansell J, et al. Oral Anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119:8S–21S.
Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, et al. Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation. J Cardiol. 2016;68(6):517–22.
Rosendaal F, Cannegieter S, Van der Meer F, Briet E. A Method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236–9.
Rose A, Berlowitz D, Frayne S, Hylek E. Measuring Quality of Oral Anticoagulation care: extending quality measurement to a new field. Jt Comm J Qual Patient Saf. 2009;35(3):146–55.
Sargent R, Brocklebank C, Tam-Tham H, Williamson T, Quail P, Turner D, et al. Advantages of a warfarin protocol for long-term care pharmacists: a retrospective cohort study. Can Geriatr J. 2016;19(2):40–9.
Verhovsek M, Motlagh B, Crowther M, Kennedy C, Dolovich L, Campbell G, et al. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr. 2008;8:13.
Davis N, Billett H, Cohen H, Arnsten J. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632–6.
Esmerio F, Souza E, Leiria T, Lunelli R, Moraes M. Constant use of oral anticoagulants: implications in the control of their adequate levels. Arq Bras Cardiol. 2009;93(5):549–54.
Ryals C, Pierce K, Baker J. INR Goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a veterans affairs medical center. J Manag Care Pharm. 2011;17(2):133–42.
Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica. 2002;87(10):1081–6.
Matalqah L, Radaideh K, Sulaiman S, Hassali M, Abdul Kader M. Relationship between patients’ warfarin knowledge and anticoagulation control: results of a validated tool in Malaysia. J Pharm Biomed Sci. 2013;30(30):967–74.
Kimmel S, Chen Z, Price M, Parker C, Metlay J, Christie J, et al. The Influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med. 2007;167(3):229–35.
Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol. 2014;77(3):427–45.
Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–82.
Acknowledgements
The authors would like to acknowledge the administrative team at the Security Forces Hospital in Riyadh for their approval and support to conduct the study. We are grateful to all patients who agreed to participate in the survey and contribute to this research, and we are grateful to all of the cardiologists at the hospital for clinical data acquisition.
Funding
There were no external funding sources for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
There are no potential conflicts of interest to report.
Rights and permissions
About this article
Cite this article
Shilbayeh, S.A.R., Almutairi, W.A., Alyahya, S.A. et al. Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic. Int J Clin Pharm 40, 56–66 (2018). https://doi.org/10.1007/s11096-017-0569-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-017-0569-5